FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

DATA COMPILATION
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

HYDROCORTISONE ACETATE 1%; PRAMOXINE HYDROCHLORIDE 1%

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

56 API Suppliers, 15 USDMF, 11 CEP/COS, 2 JDMF, 5 EU WC, 4 KDMF, 17 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

182 FDF Dossiers, 55 FDA Orange Book, 89 Europe, 13 Canada, 13 Australia, 6 South Africa, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;RECTAL - 10%, CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION/DROPS;OTIC - EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML, AEROSOL, METERED;TOPICAL - 1%;1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 4 SPI Pharma, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 2 Gangwal Healthcare, 13 Nanjing Well Pharmaceutical, 10 Kirsch Pharma, 1 ACG Worldwide, 18 Actylis, 1 Aeon Procare, 2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 42 BASF, 8 Beneo, 1 BioSpectra, 3 CD Formulation, 15 Corel Pharma Chem, 1 Doshion Polyscience, 3 Esteem Industries, 4 Finar, 13 Gangwal Chemicals, 2 Gloria Interchem, 3 Ideal Cures, 9 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Lubrizol Life Science Health, 7 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 21 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries, 1 Symrise, 2 The Dow Chemical Company, 2 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Topical, 50 Solubilizers, 43 Coating Systems & Additives, 33 Thickeners and Stabilizers, 33 Parenteral, 26 Fillers, Diluents & Binders, 25 Controlled & Modified Release, 24 Emulsifying Agents, 21 Film Formers & Plasticizers, 20 Taste Masking, 16 Surfactant & Foaming Agents, 16 Granulation, 14 Direct Compression, 10 Lubricants & Glidants, 7 API Stability Enhancers, 5 Co-Processed Excipients, 5 Empty Capsules, 5 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 Rheology Modifiers, 2 Disintegrants & Superdisintegrants, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 7 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 7 Regulatory FDF Prices

MARKET PLACE

20 APIs, 2 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
27/02/2026	Curia	U.S.A	CURIA SPAIN S.A.U. Boecillo ES	CEP 2019-270 - Rev 02	Hydrocortisone acetate	2025-12-17	Valid	Chemical		334
27/02/2026	Pfizer CentreOne	U.S.A	PHARMACIA & UPJOHN COMPANY LLC Kalamazoo US	CEP 2002-160 - Rev 05	Hydrocortisone acetate, Micronised	2024-12-11	Valid	Chemical		334

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

HYDROCORTISONE ACETATE 1%; PRAMOXINE HYDROCHLORIDE 1%

HYDROCORTISONE ACETATE 1%; PRAMOXINE HYDROCHLORIDE 1%

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

56 API Suppliers

15 USDMF

11 CEP/COS

2 JDMF

5 EU WC

4 KDMF

17 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

182 FDF Dossiers

55 FDA Orange Book

89 Europe

13 Canada

13 Australia

6 South Africa

6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

AEROSOL, METERED;RECTAL - 10%

CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION/DROPS;OTIC - EQ 3MG BASE/ML;10MG/ML;EQ 3.3MG BASE/ML;0.5MG/ML

AEROSOL, METERED;TOPICAL - 1%;1%

RELATED EXCIPIENT COMPANIES

2 EUROAPI

3 Rochem International Inc

4 SPI Pharma

1 Pharm-RX Chemical

1 Boai NKY Pharmaceuticals Ltd

2 Gangwal Healthcare

13 Nanjing Well Pharmaceutical

10 Kirsch Pharma

1 ACG Worldwide

18 Actylis

1 Aeon Procare

2 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

42 BASF

8 Beneo

1 BioSpectra

3 CD Formulation

15 Corel Pharma Chem

1 Doshion Polyscience

3 Esteem Industries

4 Finar

13 Gangwal Chemicals

2 Gloria Interchem

3 Ideal Cures

9 Kerry

3 Kima Chemical

6 Lonza Capsugel

7 Lubrizol Life Science Health

7 Microlex e.U

2 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

1 Pharmatrans-Sanaq

3 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

21 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

1 Symrise

2 The Dow Chemical Company

2 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Topical

50 Solubilizers

43 Coating Systems & Additives

CREAM;TOPICAL - 0.5%;EQ 3.5MG BASE/GM;10,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons